We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:BCAX
​
​
logo

Bicara Therapeutics Inc. (BCAX)

Nasdaq • BCAX • US0554771032

8.65Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 29.5% of free float sold short, 13.1 days to cover, cost to borrow 0.27%. Sign up for live short interest data.

Market Cap

572m USD | # 5781 in US

Volume

1.09m shares | 21.56m USD

Shares Outstanding

66.17m

Free Float Shares

55.76% | 36.9m

News

BCAX key data

Bicara Therapeutics Inc. (Nasdaq: BCAX) has a market capitalization of $572.4M. Last close $8.65 (as of 2026-11-09); 52-week range $7.87 to $30.99. ORTEX data as of 2026-10-22: short interest was 29.46% of free float, 13.1 days to cover and the average cost to borrow was 0.27%. Sign up for live short interest data.

  • BCAX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.